Pyridil carboxamides as 5HT2B/2C receptor antagonists
申请人:SmithKline Beecham p.l.c.
公开号:US05922733A1
公开(公告)日:1999-07-13
Novel heterocyclic compounds having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of CNS disorders are disclosed.
BENZOCONDENSED FIVE MEMBERED HETEROCYCLE CARBOXAMIDES AS 5HT2B/2C RECEPTOR ANTAGONISTS
申请人:SMITHKLINE BEECHAM PLC
公开号:EP0770076A1
公开(公告)日:1997-05-02
US5922733A
申请人:——
公开号:US5922733A
公开(公告)日:1999-07-13
[EN] BENZOCONDENSED FIVE MEMBERED HETEROCYCLE CARBOXAMIDES AS 5HT2B/2C RECEPTOR ANTAGONISTS<br/>[FR] CARBOXAMIDES HETEROCYCLIQUES BENZO-CONDENSES A CINQ ELEMENTS UTILISES COMME ANTAGONISTES DE RECEPTEUR DE 5HT2B/2C
申请人:SMITHKLINE BEECHAM PLC
公开号:WO1996002537A1
公开(公告)日:1996-02-01
(EN) Novel heterocyclic compounds having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of CNS disorders are disclosed.(FR) Nouveaux composés hétérocycliques à activité pharmacologique, procédés destinés à leur préparation, compositions les contenant et leur utilisation dans le traitement de troubles du système nerveux central.